Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Altria Group
MO
|
+$428M |
| 2 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$232M |
| 3 |
Grayscale Bitcoin Trust
GBTC
|
+$208M |
| 4 |
Morgan Stanley Direct Lending Fund
MSDL
|
+$201M |
| 5 |
Infosys
INFY
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$50.9B |
| 2 |
Apple
AAPL
|
+$38.9B |
| 3 |
Amazon
AMZN
|
+$26B |
| 4 |
NVIDIA
NVDA
|
+$23.3B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.37% |
| 2 | Financials | 10.81% |
| 3 | Healthcare | 9.76% |
| 4 | Consumer Discretionary | 9.08% |
| 5 | Industrials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5676
Offerpad Solutions
OPAD
$23.5M
| $147K | ﹤0.01% |
1,821
-1,517
| -45% | -$133K |
|
5677
Origin Agritech
SEED
$12.1M
| $147K | ﹤0.01% |
36,356
-34,556
| -49% | -$86.8K |
|
|
HEWG
5678
DELISTED
iShares Currency Hedged MSCI Germany ETF
HEWG
| $146K | ﹤0.01% |
4,125
-4,125
| -50% | -$137K |
|
5679
IHS Holding
IHS
$2.76B
| $146K | ﹤0.01% |
41,242
-49,932
| -55% | -$170K |
|
5680
Real Brokerage
REAX
$379M
| $145K | ﹤0.01% |
46,424
-16,522
| -26% | -$45.3K |
|
5681
US Vegan Climate ETF
VEGN
$186M
| $145K | ﹤0.01% |
3,088
-3,088
| -50% | -$139K |
|
|
FENG
5682
Phoenix New Media
FENG
$18.3M
| $144K | ﹤0.01% |
74,461
-83,059
| -53% | -$128K |
|
|
HYPD
5683
Hyperion DeFi Inc
HYPD
$41.4M
| $144K | ﹤0.01% |
1,828
-732
| -29% | -$99.6K |
|
5684
Clene
CLNN
$67.5M
| $144K | ﹤0.01% |
16,932
-16,932
| -50% | -$146K |
|
|
ELEV
5685
DELISTED
Elevation Oncology
ELEV
| $144K | ﹤0.01% |
28,072
+21,218
| +310% | +$68.7K |
|
5686
Tempest Therapeutics
TPST
$14.2M
| $144K | ﹤0.01% |
2,830
-2,065
| -42% | -$104K |
|
5687
Gaia
GAIA
$48.4M
| $144K | ﹤0.01% |
46,661
-46,827
| -50% | -$137K |
|
5688
Cartesian Therapeutics
RNAC
$237M
| $144K | ﹤0.01% |
7,365
-11,627
| -61% | -$247K |
|
|
CCRD
5689
DELISTED
CoreCard
CCRD
| $144K | ﹤0.01% |
12,993
-27,929
| -68% | -$332K |
|
5690
Lifetime Brands
LCUT
$197M
| $143K | ﹤0.01% |
13,670
+11,758
| +615% | +$103K |
|
5691
Strategy Shares Nasdaq 7HANDL Index ETF
HNDL
$638M
| $143K | ﹤0.01% |
6,750
-7,894
| -54% | -$164K |
|
5692
Oxford Square Capital
OXSQ
$158M
| $143K | ﹤0.01% |
45,158
-47,620
| -51% | -$146K |
|
|
OPOF
5693
DELISTED
Old Point Financial
OPOF
| $143K | ﹤0.01% |
8,062
-8,258
| -51% | -$143K |
|
5694
Outlook Therapeutics
OTLK
$180M
| $143K | ﹤0.01% |
11,973
-38,474
| -76% | -$311K |
|
5695
Swvl Holdings
SWVL
$13.5M
| $143K | ﹤0.01% |
12,026
+560
| +5% | +$3.19K |
|
5696
Aptus Collared Investment Opportunity ETF
ACIO
$2.43B
| $142K | ﹤0.01% |
3,943
+3,927
| +24,544% | +$136K |
|
5697
Rallybio
RLYB
$84.7M
| $141K | ﹤0.01% |
9,548
-15,232
| -61% | -$212K |
|
5698
Renaissance IPO ETF
IPO
$162M
| $141K | ﹤0.01% |
3,393
-3,393
| -50% | -$127K |
|
5699
First Trust Asia Pacific ex-Japan AlphaDEX Fund
FPA
$107M
| $141K | ﹤0.01% |
5,091
-9,919
| -66% | -$266K |
|
5700
Innovator US Equity Buffer ETF January
BJAN
$347M
| $140K | ﹤0.01% |
3,225
-3,225
| -50% | -$136K |
|
Similar funds
Morgan Stanley's Q1 2024 Portfolio in Review
As of Q1 2024, Morgan Stanley held 8,154 positions worth $1.25T, down 45% from $2.27T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Morgan Stanley withdrew a net $1.16T in Q1 2024, closing 331 positions and reducing 6,748 holdings. Its most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $725M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Morgan Stanley opened a new position in Grayscale Bitcoin Trust worth $270M.
- Morgan Stanley's largest Q1 2024 buy was Grayscale Bitcoin Trust: 4,729,259 shares worth $270M.
- Morgan Stanley added most to Altria Group in Q1 2024, an estimated $428M increase.
- Morgan Stanley's biggest Q1 2024 reduction was Microsoft, cutting an estimated $50.9B.
- Morgan Stanley fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $725M.
- Morgan Stanley's ten largest holdings make up 19% of its $1.25T portfolio in Q1 2024.
- Morgan Stanley opened 333 new positions and closed 331 in Q1 2024.
- Morgan Stanley's portfolio value fell 45% quarter-over-quarter to $1.25T.
Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.